Antimalarials inhibit hematin crystallization by unique drug-surface site interactions.

Area of Science:

• Malaria Pathophysiology
• Drug Discovery
• Crystallography

Background:

• Divergent hypotheses exist regarding how antimalarial drugs inhibit hematin crystallization.
• Current theories suggest drugs act via soluble hematin sequestration or crystal surface interaction.

Purpose of the Study:

• To elucidate the precise mechanisms by which quinoline antimalarials interact with beta-hematin crystals.
• To determine the efficacy of soluble hematin complexation versus crystal surface interaction in drug action.

Main Methods:

• Time-resolved in situ surface observations of beta-hematin crystallization.
• Analysis of quinoline antimalarial interactions with crystal surfaces and soluble hematin.

Main Results:

• Quinoline antimalarials inhibit beta-hematin crystal growth via three distinct mechanisms: step pinning, kink blocking, and step bunch induction.
• Kink blocking, while validating classical theory, is not the most effective inhibition pathway.
• Hematin complexation by quinolines is insufficient for heme detoxification and a poor predictor of drug specificity.

Conclusions:

• Drug-crystal interactions are crucial for antimalarial drug efficacy.
• Understanding these interactions provides a basis for rational design of novel antimalarial compounds.